-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Lifecore Biomedical, Inc. \De\ quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q3 2010 to Q3 2024.
- Lifecore Biomedical, Inc. \De\ Net Cash Provided by (Used in) Operating Activities for the quarter ending August 25, 2024 was -$643K, a 92.3% increase year-over-year.
- Lifecore Biomedical, Inc. \De\ annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$217K, a 98.8% increase from 2022.
- Lifecore Biomedical, Inc. \De\ annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$17.4M, a 22.8% increase from 2021.
- Lifecore Biomedical, Inc. \De\ annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$22.6M, a 237% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)